Published in Vaccine Weekly, August 10th, 2011
"Acting as an adjuvant, the glycolipid induced an enhanced Th1-biased allergen-specific immune response of autologous lymphocytes. In a mouse model of allergic airway inflammation, alpha GalCerMPEG-activated NKT cells promoted a cytokine environment in the spleen, leading to priming of Th1...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly